Who owns RAIN THERAPEUTICS INC?
- CUSIP Number: 75082q105
Tip: Access positions for across all investors
Analyze quarterly positions in Rain Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Rain Therapeutics stock
Who bought or sold RAIN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tang Capital Management | 3.9M | $4.6M | 3% | Dec 2023 |
|
| BVF | 3.5M | $4.2M | 0% | Dec 2023 |
|
| Samsara BioCapital | 2.0M | $2.4M | 0% | Dec 2023 |
|
| Boxer Capital | 1.2M | $1.4M | 0% | Dec 2023 |
|
| Vanguard Group | 873k | $1.0M | -3% | Dec 2023 |
|
| Acuitas Investments | 411k | $539k | 0% | Dec 2023 |
|
| Two Sigma Advisers | 157k | $189k | -28% | Dec 2023 |
|
| Two Sigma Investments | 110k | $132k | -41% | Dec 2023 |
|
| Marquette Asset Management | 102k | $122k | 21% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 100k | $120k | 0% | Dec 2023 |
|
| Gts Securities | 50k | $60k | 100% | Dec 2023 |
|
| Jane Street | 45k | $54k | 100% | Dec 2023 |
|
| Alliancebernstein | 43k | $51k | 0% | Dec 2023 |
|
| Bank of New York Mellon | 42k | $50k | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 39k | $47k | 0% | Dec 2023 |
|
| PenderFund Capital Management | 39k | $62k | 100% | Dec 2023 |
|
| Virtu Financial | 33k | $40k | 100% | Dec 2023 |
|
| Citadel Advisors | 30k | $36k | 40% | Dec 2023 |
|
| UBS Group | 29k | $35k | 239% | Dec 2023 |
|
| Russell Investments | 25k | $30k | -94% | Dec 2023 |
|
| Barclays | 24k | $29k | 884% | Dec 2023 |
|
| Horizon Kinetics Asset Management | 24k | $29k | -4% | Dec 2023 |
|
| Advisor Group Holdings | 24k | $29k | 5% | Dec 2023 |
|
| Neuberger Berman Group | 22k | $26k | 78% | Dec 2023 |
|
| Shay Capital | 22k | $26k | -32% | Dec 2023 |
|
| Bank of America Corporation | 19k | $23k | 74% | Dec 2023 |
|
| Jpmorgan Chase & Co | 17k | $21k | 50% | Dec 2023 |
|
| Rhumbline Advisers | 16k | $19k | -13% | Dec 2023 |
|
| American International | 8.8k | $11k | 4% | Dec 2023 |
|
| Wells Fargo & Company | 5.2k | $6.3k | 30% | Dec 2023 |
|
| Advisory Services Network | 4.2k | $5.1k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 3.8k | $5.0k | 41% | Dec 2023 |
|
| Citigroup | 2.6k | $3.1k | 955% | Dec 2023 |
|
| Parallel Advisors | 2.3k | $2.7k | 0% | Dec 2023 |
|
| Legal & General Group | 1.9k | $2.3k | 0% | Dec 2023 |
|
| Summit Investment Advisors | 1.4k | $1.7k | 0% | Dec 2023 |
|
| New York State Common Retirement Fund | 1.4k | $2.0k | 0% | Dec 2023 |
|
Who sold out of Rain Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BML Capital Management | Dec 2023 | 1.3M | $1.6M |
| Deltec Asset Management | Dec 2023 | 374k | $449k |
| Exchange Traded Concepts | Dec 2023 | 171k | $205k |
| Pvg Asset Management | Sep 2023 | 48k | $41k |
| Goldman Sachs Group | Sep 2023 | 28k | $25k |
| Schonfeld Strategic Advisors | Sep 2023 | 26k | $22k |
| Amalgamated Bank | Dec 2023 | 1.7k | $2.0k |